Efficacy and Safety of Combination of Brompheniramine and Phenylephrine for the Symptoms Relief of Rhinitis
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is a multicenter clinical trial, phase III, superiority, controlled by active medicine,
double-blind, randomized, enroll 166 children, over 12 years old, with acute inflammation
upper airway, characterized by nasal congestion and runny nose, lasting at least 24 hours and
a maximum of 48 hours prior to inclusion. The subjects will be allocated in 2 parallel
groups, and will receive the medicines of study, according of the randomization.